Drug companies aren’t making new antibiotics. Is there an economic cure?
PBS NewsHour - 08/04/2017
As drug-resistant infections proliferate, financial barriers are preventing the pharmaceutical industry from investing in new drugs to fight off superbugs. Economics correspondent Paul Solman, in a series of reports with science correspondent Miles O’Brien, explores how researchers, including Northeastern professor Slava Epstein, could be incentivized to develop new antibiotics.